Sandoz ranitidine recalls
The FDA has published 3 recalls involving Sandoz ranitidine since 2019. The latest was reported on 16 Oct 2019. Most were for nitrosamine impurity. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 16 Oct 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why sandoz ranitidine is recalled
Companies
By year
All sandoz ranitidine recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Ranitidine Hydrochloride Capsules 300mg recalled by Sandoz | Sandoz | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Ranitidine Hydrochloride Capsules 150mg recalled by Sandoz | Sandoz | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Ranitidine Hydrochloride Capsules 150mg recalled by Sandoz | Sandoz | Nitrosamine Impurity | Nationwide |
Should you stop taking Sandoz ranitidine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.